Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ludwig, Kirsten ^a   Tse, Edison S ^a   Wang, Jean Y J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ABELSON KINASE; BETA CATENIN; EPIDERMAL GROWTH FACTOR; F ACTIN; GEFITINIB; GROWTH FACTOR; IMATINIB; MATRIGEL; NOGGIN; PROTEIN KINASE B; SPONDIN 1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN; WNT3A PROTEIN; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CONTACT; CELL STIMULATION; CELL STRUCTURE; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INTESTINE CRYPT; INTRACELLULAR SIGNALING; PHENOTYPE; PROTEIN EXPRESSION; SPHEROID CELL; TUMOR MICROENVIRONMENT; CELL PROLIFERATION; COLON TUMOR; CONFOCAL MICROSCOPY; CULTURE TECHNIQUE; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELL LINE; HT 29 CELL LINE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; COLONIC NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELLS; HT29 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, CONFOCAL; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84876821077     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-221     Document Type: Article

References (34)

1. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2003, 83(2):337-376.
2. Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, Kundt G, Friese K. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001, 19(4):960-971.
3. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010, 15(2):117-134. 10.1007/s10911-010-9178-9, 2886089, 20490631.
4. Symons M, Segall JE. Rac and Rho driving tumor invasion: who's at the wheel?. Genome Biol 2009, 10(3):213. 10.1186/gb-2009-10-3-213, 2690992, 19291272.
5. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001, 98(18):10356-10361. 10.1073/pnas.171610498, 56965, 11526241.
6. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487(7407):330-337. 10.1038/nature11252, 3401966, 22810696.
7. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011, 474(7351):318-326. 10.1038/nature10212, 21677748.
8. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127(3):469-480. 10.1016/j.cell.2006.10.018, 17081971.
9. Bowman A, Nusse R. Location, location, location: FoxM1 mediates beta-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell 2011, 20(4):415-416. 10.1016/j.ccr.2011.10.003, 22014565.
10. Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci USA 2007, 104(39):15418-15423. 10.1073/pnas.0707210104, 2000506, 17881565.
11. Wei Q, Yokota C, Semenov MV, Doble B, Woodgett J, He X. R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. J Biol Chem 2007, 282(21):15903-15911. 10.1074/jbc.M701927200, 17400545.
12. Zhang HH, Walker F, Kiflemariam S, Whitehead RH, Williams D, Phillips WA, Mikeska T, Dobrovic A, Burgess AW. Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. Int J Cancer 2009, 125(2):297-307. 10.1002/ijc.24289, 19378335.
13. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30(3):256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
14. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459(7244):262-265. 10.1038/nature07935, 19329995.
15. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011, 141(5):1762-1772. 10.1053/j.gastro.2011.07.050, 21889923.
16. Kuntzer J, Eggle D, Lenhof HP, Burtscher H, Klostermann S. The Roche Cancer Genome Database (RCGDB). Hum Mutat 2010, 31(4):407-413. 10.1002/humu.21207, 20127971.
17. Nishioka M, Ueno K, Hazama S, Okada T, Sakai K, Suehiro Y, Okayama N, Hirata H, Oka M, Imai K. Possible involvement of Wnt11 in colorectal cancer progression. Mol Carcinog 2013, 52(3):207-217. 10.1002/mc.21845, 22161723.
18. Planutis K, Planutiene M, Moyer MP, Nguyen AV, Perez CA, Holcombe RF. Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol 2007, 8:12. 10.1186/1471-2121-8-12, 1847812, 17386109.
19. Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer 2009, 101(8):1374-1381. 10.1038/sj.bjc.6605307, 2768449, 19773752.
20. Feng Y, Dai X, Li X, Wang H, Liu J, Zhang J, Du Y, Xia L. EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif 2012, 45(5):413-419. 10.1111/j.1365-2184.2012.00837.x, 22925500.
21. Gao Y, Kitagawa K, Hiramatsu Y, Kikuchi H, Isobe T, Shimada M, Uchida C, Hattori T, Oda T, Nakayama K. Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Res 2006, 66(24):11623-11631. 10.1158/0008-5472.CAN-06-2629, 17178856.
22. Qi L, Sun B, Liu Z, Li H, Gao J, Leng X. Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci 2012, 103(4):828-835. 10.1111/j.1349-7006.2012.02222.x, 22321022.
23. Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R, Barrow D, Nicholson RI. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 2006, 118(2):290-301. 10.1002/ijc.21355, 16080193.
24. Foroni C, Broggini M, Generali D, Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012, 38(6):689-697. 10.1016/j.ctrv.2011.11.001, 22118888.
25. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119(6):1420-1428. 10.1172/JCI39104, 2689101, 19487818.
26. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310(5751):1139-1143. 10.1126/science.1116995, 16293750.
27. Solon J, Levental I, Sengupta K, Georges PC, Janmey PA. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J 2007, 93(12):4453-4461. 10.1529/biophysj.106.101386, 2098710, 18045965.
28. Levental I, Georges PC, Janmey PA. Soft biological materials and their impact on cell function. Soft Matter 2007, 3(3):299-306.
29. Schwartz MA. Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2010, 2(12):a005066. 10.1101/cshperspect.a005066, 2982167, 21084386.
30. Bujanda L, Cosme A, Gil I, Arenas-Mirave JI. Malignant colorectal polyps. World J Gastroenterol 2010, 16(25):3103-3111. 10.3748/wjg.v16.i25.3103, 2896747, 20593495.
31. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008, 299(9):1027-1035. 10.1001/jama.299.9.1027, 18319413.
32. Uronis JM, Herfarth HH, Rubinas TC, Bissahoyo AC, Hanlon K, Threadgill DW. Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res 2007, 67(24):11594-11600. 10.1158/0008-5472.CAN-07-3242, 18089788.
33. Takahashi T, Nosho K, Yamamoto H, Mikami M, Taniguchi H, Miyamoto N, Adachi Y, Itoh F, Imai K, Shinomura Y. Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol 2007, 20(1):139-147. 10.1038/modpathol.3800722, 17143260.
34. Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, Willert K, Solnica-Krezel L, Coffey RJ. Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane. J Biol Chem 2010, 285(18):13561-13568. 10.1074/jbc.M109.075945, 2859517, 20177058.